Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Molecular Cell Biology Research Communications : MCBRC|November 30, 1999
Transcriptional activation of the cyclin-dependent kinase inhibitor p21 by PML/RARalphaW L Yang, Y X Zeng, W S El-Deiry, et al.
Molecular and Cellular Biology|April 17, 1999
Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a)J Mitra, C Y Dai, K Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interactionN S Prabhu, M V Blagosklonny, Y X Zeng, et al.
International Journal of Oncology|July 13, 1999
The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicityN S Prabhu, K Somasundaram, H Tian, et al.
Cancer Research|August 29, 1998
Rare loss-of-function mutation of a death receptor gene in head and neck cancerS I Pai, G S Wu, N Ozören, et al.
Cancer Research|June 26, 1999
Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cellsS Y Sun, P Yue, G S Wu, et al.
Oncogene|May 18, 1999
Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cellsS Y Sun, P Yue, G S Wu, et al.
The EMBO Journal|November 15, 2001
hADA3 is required for p53 activityT Wang, T Kobayashi, R Takimoto, et al.
Oncogene|May 15, 1998
BRCA1 physically associates with p53 and stimulates its transcriptional activityH Zhang, K Somasundaram, Y Peng, et al.
The Journal of Biological Chemistry|January 25, 2000
BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expressionT K MacLachlan, K Somasundaram, M Sgagias, et al.
Pageof 9